Verrica Pharmaceuticals
VRCA
#9272
Rank
A$0.10 B
Marketcap
$1.11
Share price
2.65%
Change (1 day)
-88.94%
Change (1 year)

Earnings for Verrica Pharmaceuticals (VRCA)

Earnings in 2024 (TTM): -A$0.12 Billion

According to Verrica Pharmaceuticals's latest financial reports the company's current earnings are A$9.21 Million. In 2023 the company made an earning of -A$0.11 Billion a decrease over its 2022 earnings that were of -A$35.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verrica Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.12 Billion11.37%
2023 -A$0.11 Billion183.19%
2022 -A$35.56 Million-27.7%
2021 -A$49.18 Million-22.38%
2020 -A$63.36 Million38.87%
2019 -A$45.63 Million44.49%
2018 -A$31.58 Million343.48%
2017 -A$7.12 Million